Dr. Morrow is professor emerita at the University of Cincinnati and Cincinnati Children’s Hospital, where she heads the human milk research laboratory and directs the CDC-funded PREVAIL birth cohort study and trials on human milk oligosaccharide and the microbiota.
She obtained her MSc in nutrition from the University of the West Indies in Kingston, Jamaica, and her PhD from the University of Texas in epidemiology. She has more than 160 publications on infant nutrition and child health, and is a leading expert in human milk composition. Her career has focused on human milk protection against infectious and inflammatory gut disorders. This focus led her to conduct seminal research on human milk oligosaccharide in infant health, the role of fucosyltransferase2 (FUT2) gene enzyme in modifying human milk and infant gut oligosaccharide profile and its impact on infant disease and the infant gut microbiota.
She founded two divisions of epidemiology and public health sciences, in Virginia and Ohio, served as the PI of an NIH program project on human milk for 15 years, has directed multiple NIH and CDC-funded studies in term and preterm infants, and has conducted multi-site studies involving locations in the US, Mexico, and China. Altogether, Dr. Morrow has been awarded more than $25 million in grants from NIH, CDC, industry and foundations.
She served as President of the International Society for Research in Human Milk and Lactation, and the director of two academic divisions. She has served as a mentor on many training grants, as a reviewer on multiple grant study sections, and a participant on multiple expert panels and study sections, including for NIH and Gates Foundation.